Trials / Conditions / Ischemic Heart Failure

Ischemic Heart Failure

16 registered clinical trials studyying Ischemic Heart Failure — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart Disease NCT07471698	HELP Therapeutics Co., Ltd.	Phase 1 / Phase 2
Not Yet Recruiting	Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF NCT07347197	Heartseed Inc.	Phase 1 / Phase 2
Recruiting	CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction NCT06258447	BioCardia, Inc.	N/A
Unknown	Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure NCT05566600	HELP Therapeutics Co., Ltd.	EARLY_Phase 1
Completed	Clinical Study of Lipoic Acid on Ischemic Heart Failure NCT03491969	Shanghai Zhongshan Hospital	Phase 4
Unknown	A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome) NCT02875639	Zhu Mingjun	Phase 2
Unknown	Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure NCT03206593	Guangdong Provincial People's Hospital	—
Terminated	PARACHUTE China Approval Trial NCT02240940	CardioKinetix, Inc	N/A
Completed	LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry NCT02700880	Zoll Medical Corporation	—
Unknown	Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203 NCT02115568	Juventas Therapeutics, Inc.	—
Unknown	Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure NCT01961726	Juventas Therapeutics, Inc.	Phase 1 / Phase 2
Unknown	Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart Failure NCT01709279	Kanazawa University	N/A
Unknown	Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure. NCT01643590	Juventas Therapeutics, Inc.	Phase 2
Unknown	Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure NCT01555320	State Administration of Traditional Chinese Medicine of the People's Republic of China	N/A
Completed	Resynchronization Surgery Combined Unified Efficacy NCT00846001	Meshalkin Research Institute of Pathology of Circulation	Phase 3
Terminated	Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh NCT00102128	Genzyme, a Sanofi Company	Phase 2